Drugs that activate the cells’ proteasome, or recycling center, tip the balance in favor of memory CD8+ T cells, studies on mice show. This approach could be used to improve how well vaccines and immunotherapies work and how long they last.
Drugs that activate the cells’ proteasome, or recycling center, tip the balance in favor of memory CD8+ T cells, studies on mice show. This approach could be used to improve how well vaccines and immunotherapies work and how long they last.